Working… Menu

MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02088112
Recruitment Status : Completed
First Posted : March 14, 2014
Last Update Posted : April 13, 2021
Information provided by (Responsible Party):
MedImmune LLC